Publications by authors named "Paula Martin Garcia"
Article Synopsis
- Inflammatory bowel disease (IBD) comprises ulcerative colitis and Crohn's disease, with increasing prevalence globally.
- This systematic review examined the effectiveness, safety, and cost-effectiveness of TNF antagonist therapies in treating pediatric IBD, analyzing data from randomized clinical trials and economic evaluations.
- Results indicated that anti-TNF drugs like infliximab and adalimumab are likely effective and safe for maintenance treatment in children, although the economic evaluations showed mixed conclusions regarding their cost-effectiveness.
We report the case of a 29-year-old male with structuring ileocolic Crohn's disease (CD), diagnosed in 2007 and treated with oral azathioprine, oral mesalazine and intravenous infliximab, without any other surgical or medical history of interest. He presented to the Emergency Room with abdominal distention and pain, nausea, vomiting and motility problems of a three-day duration. An abdominal computerized tomography using intravenous contrast was performed.
View Article and Find Full Text PDF